Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ustekinumab in adolescent plaque psoriasis (CADMUS)
NCT01090427Phase 3Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- May 2010
- Primary completion
- Jan 2013
- Modality
- Monoclonal Antibodies
- Countries
- 10
01
Overview
A Phase 3 trial of ustekinumab in plaque psoriasis, sponsored by Janssen Pharmaceutical. Started May 2010; status: completed.
02
Drugs
ustekinumab
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT01090427.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01090427.